Small bowel tumors detected and missed during capsule endoscopy: Single center experience

Table 1 Characteristics of the study population n (%)

Gender, males	71/145 (49)
Age
(min, max)	(8, 85)
mean (SD)	50.1 (19.2)
Main indication for CE1	n = 1502
Overt obscure bleeding	58 (38.7)
Occult obscure bleeding	23 (15.3)
Anemia	19 (12.7)
Malabsorption	18 (12.0)
Abnormal SB follow through	9 (6.0)
Abdominal pain	7 (4.7)
Celiac disease	5 (3.3)
Neuroendocrine tumor	3 (2.0)
Peutz-Jeghers syndrome	2 (1.3)
Diarrhea	2 (1.3)
Crohn’s disease	2 (1.3)
Polyposis syndrome	2 (1.3)

¹Primary indication was given;

²Capsule endoscopy (CE) was performed twice in 5 patients for the following reasons: incomplete examination (2 patients); recurring overt obscure gastrointestinal bleeding (OGIB) in a patient with normal first examination (1 patient) and recurring overt gastrointestinal bleeding in patients with abnormal first CE result and treatment instituted (mucosal breaks, angioectasias, 2 patients).